TY - JOUR
T1 - … and how the decisions are made
AU - Danovitch, Gabriel M.
AU - Wilkinson, Alan
AU - Rosenthal, J. Thomas
AU - Zimecki, Michael W.
AU - Levenback, Charles
AU - Pader, Elmer
AU - Hubbard, Ruth
AU - Boren, Stephen D.
PY - 1994/8/4
Y1 - 1994/8/4
N2 - To the Editor: We have some pretty tough days too, for in addition to the clinical, academic, and administrative functions that are part of our careers, we now have to spend many hours persuading health insurance companies that we are not trying to manipulate them into paying more money than Medicare does for kidney transplants, as Dr. Boren insinuates (Feb. 17 issue)1. He is making his work unnecessarily difficult by equating understandably difficult decisions about whether to approve autologous bone marrow transplantation for patients with metastatic breast cancer with decisions about approval of predialysis transplantation for patients with end-stage.
AB - To the Editor: We have some pretty tough days too, for in addition to the clinical, academic, and administrative functions that are part of our careers, we now have to spend many hours persuading health insurance companies that we are not trying to manipulate them into paying more money than Medicare does for kidney transplants, as Dr. Boren insinuates (Feb. 17 issue)1. He is making his work unnecessarily difficult by equating understandably difficult decisions about whether to approve autologous bone marrow transplantation for patients with metastatic breast cancer with decisions about approval of predialysis transplantation for patients with end-stage.
UR - http://www.scopus.com/inward/record.url?scp=0028764434&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028764434&partnerID=8YFLogxK
U2 - 10.1056/NEJM199408043310515
DO - 10.1056/NEJM199408043310515
M3 - Letter
C2 - 8022455
AN - SCOPUS:0028764434
SN - 0028-4793
VL - 331
SP - 331
EP - 332
JO - New England Journal of Medicine
JF - New England Journal of Medicine
IS - 5
ER -